Industry groups cite flaws in JAMA Cardiology paper downplaying omega-3’s cardiovascular benefits
Dietary supplement industry groups have heavily criticized a new meta-analysis in JAMA Cardiology that concluded that omega-3 fatty acid supplementation had no significant impact on fatal or nonfatal coronary heart disease or any major vascular events.